Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
HAIFA, Israel, Sept. 6, 2015 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, today announced its President and...
-
OMER, Israel, Sept. 6, 2015 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization...
-
VANCOUVER, British Columbia, Sept. 4, 2015 (GLOBE NEWSWIRE) -- QLT Inc. (NASDAQ:QLTI) (TSX:QLT) ("QLT" or the "Company") announces that it has been advised by InSite Vision Incorporated ("InSite")...
-
VALENCIA, Calif., Sept. 4, 2015 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) today announced the renewal of its shelf Registration Statement on Form S-3, as filed with the Securities and...
-
TORONTO, Sept. 4, 2015 (GLOBE NEWSWIRE) -- Sprott Focus Trust, Inc. (Nasdaq:FUND) (the "Fund" or "FUND") has declared a quarterly distribution of $0.10 per share on its Common Stock. The distribution,...
-
BATON ROUGE, La., Sept. 04, 2015 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), one of America's leading home health and hospice companies, today announced that it will participate in the...
-
ATLANTA, Sept. 4, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) (the "Company"), a biopharmaceutical company focused on the discovery and development of direct-acting antivirals...
-
CAMBRIDGE, Mass. and EXTON, Pa., Sept. 4, 2015 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company developing toll-like receptor and RNA...
-
NEW YORK, Sept. 4, 2015 (GLOBE NEWSWIRE) -- National General Holdings Corp. (NASDAQ:NGHC) announced today that it will present at the Keefe, Bruyette & Woods 2015 Insurance Conference which will be...
-
THOROFARE, N.J., Sept. 4, 2015 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ:AKER) (AIM:AKR.L), (the "Company"), a medical device company focused on reducing the cost of healthcare through...